The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
PT Multi Medika Internasional Tbk has a Altman Z-Score of 29.29, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for PT Multi Medika Internasional Tbk's Altman Z-Score or its related term are showing as below:
PT Multi Medika Internasional Tbk (ISX:MMIX) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Multi Medika Internasional Tbk Altman Z-Score Chart
PT Multi Medika Internasional Tbk Annual Data
Trend
Dec20
Dec21
Altman Z-Score
0.00
0.00
PT Multi Medika Internasional Tbk Semi-Annual Data
Dec20
Dec21
Altman Z-Score
0.00
0.00
PT Multi Medika Internasional Tbk Altman Z-Score Competitor Comparison
For the Pharmaceutical Retailers subindustry, PT Multi Medika Internasional Tbk's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Multi Medika Internasional Tbk Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Multi Medika Internasional Tbk's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where PT Multi Medika Internasional Tbk's Altman Z-Score falls into.
PT Multi Medika Internasional Tbk Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
PT Multi Medika Internasional Tbk (ISX:MMIX) has a Altman Z-Score of 29.29 as of Jul. 13, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on PT Multi Medika Internasional Tbk and its competitors.
Is PT Multi Medika Internasional Tbk's Altman Z-Score too high?
PT Multi Medika Internasional Tbk's current Altman Z-Score is 29.29. The Healthcare Providers & Services industry median Altman Z-Score is 2.45. PT Multi Medika Internasional Tbk's value of 29.29 is 1095.5% above this industry median. Overall, PT Multi Medika Internasional Tbk has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does PT Multi Medika Internasional Tbk's Altman Z-Score compare to competitors?
PT Multi Medika Internasional Tbk's Altman Z-Score of 29.29 can be compared against companies in the Healthcare Providers & Services industry. The industry median Altman Z-Score is 2.45. PT Multi Medika Internasional Tbk's value of 29.29 is 1095.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.45, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Multi Medika Internasional Tbk's current Altman Z-Score of 29.29 is 1095.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on PT Multi Medika Internasional Tbk and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Multi Medika Internasional Tbk's current Altman Z-Score is 29.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Multi Medika Internasional Tbk stock overvalued right now?
PT Multi Medika Internasional Tbk (ISX:MMIX) has a current Altman Z-Score of 29.29. The current Altman Z-Score is 29.29 and 1095.5% above the Healthcare Providers & Services industry median of 2.45. PT Multi Medika Internasional Tbk's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For PT Multi Medika Internasional Tbk (ISX:MMIX), the current Altman Z-Score is 29.29 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Multi Medika Internasional Tbk Business Description
PT Multi Medika Internasional Tbk is engaged in the wholesale trading of medical devices and pharmaceutical and laboratory equipment for humans, operating lease, and non-copyrighted works. It also wholesales other food and beverages, such as rice flour, tapioca flour, bakery premix, caramel, processed honey, shrimp crackers and others; agricultural food and beverages, such as herbs and spices; livestock and fisheries; non-alcoholic beverages, such as fruit juice, soft drinks, mineral water, bottled water, and other similar products; cosmetics for humans such as perfume, soap, powder and others. Its segments include Mask and other non food and beverages, and food and beverages. It derives the majoritf of the revenue from Mask and other non food and beverages segments.
24GF Score
Get the complete analysis for ISX:MMIX
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MMIX has been successfully added to your 